F. Ostronic
Director/Board Member at CYCLO THERAPEUTICS, INC.
Net worth: 446 427 $ as of 31/05/2024
F. Ostronic active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CYCLO THERAPEUTICS, INC. | Director/Board Member | 09/04/2014 | - |
| Independent Dir/Board Member | 09/04/2014 | - | |
| The Usp Group, Inc. | Director of Finance/CFO | - | - |
| Novit US, Inc. | Director/Board Member | - | - |
| Novit LP | Corporate Officer/Principal | - | - |
Career history of F. Ostronic
Former positions of F. Ostronic
| Companies | Position | Start | End |
|---|---|---|---|
Tamir Biotechnology, Inc.
 Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Director/Board Member | 05/02/2013 | - |
Training of F. Ostronic
| College of the Holy Cross (Massachusetts) | Undergraduate Degree |
| Old Dominion University | Graduate Degree |
| The University of Maryland Francis King Carey School of Law | Graduate Degree |
Statistics
International
| United States | 9 |
Operational
| Director/Board Member | 3 |
| Graduate Degree | 2 |
| Independent Dir/Board Member | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CYCLO THERAPEUTICS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Tamir Biotechnology, Inc.
Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Health Technology |
| Novit LP | |
| The Usp Group, Inc. | |
| Novit US, Inc. |
- Stock Market
- Insiders
- F. Ostronic
- Experience
